予測マーカーMusashi-2は,拡散型大B細胞リンパ腫におけるDNA損傷反応と放射線抵抗を調節する
Timo Habig1, Lasse Reichstein1, Kathrin A Brücksken1
1Department of Radiation Oncology, University Hospital Münster, Münster, Germany.
Frontiers in cell and developmental biology
|August 22, 2025
まとめ
ムサシ2 (MSI2) は,拡散型大B細胞リンパ腫 (DLBCL) で過剰発現し,予後不良と関連しています. MSI2ノックダウンはDLBCL細胞を化学療法と放射線に敏感にし,MSI2を治療標的として示唆しています.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- 治療に対する耐性は,拡散性大B細胞リンパ腫 (DLBCL) 治療における重要な課題です.
- ムサシ (MSI) のRNA結合タンパク質は遺伝子発現を調節し,他のがんの腫瘍発生と治療失敗に関与しています.
研究 の 目的:
- DLBCLの治療効果と耐性におけるMSI族のタンパク質,特にMSI1とMSI2の役割を調査する.
- DLBCL患者におけるMSI2の予後的関連性を決定する.
主な方法:
- DLBCLにおけるMSI1およびMSI2発現と予後値の評価のために,一般に利用可能な遺伝子発現データを分析する.
- MSI2共表現ネットワークの特徴
- qPCR,ウェスタン・ブロット,タンパク質配列,フロー・サイトメトリーを用いたDLBCL細胞におけるMSI2ノックダウン実験.
- 放射線治療と化学療法 (ビンクリスティン,ドクソルビシン) の後の細胞生存率とクローン生殖生存率の評価
主要な成果:
- MSI2はDLBCLで有意に過剰表現され,予後が悪かった.
- 高いMSI2発現は,幹度とDNA修復シグナルの増加と相関する.
- MSI2のノックダウンにより,幹のマーカーが低下し,DNAの修復機能が低下し,放射線,ビンクリスティン,ドクソルビシンに対する感受性が増加した.
結論:
- MSI2はDLBCLの予後マーカーとして作用し,遺伝子毒性療法に対する感受性に影響します.
- MSI2を標的とした治療は,DLBCLのDNA標的治療の有効性を高める可能性があります.
さらに関連する動画
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
6.2K
10:04Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
10.6K
関連する概念動画
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Other Unique Bacteria
82
Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic...
82
Mutations
39.9K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
39.9K
